Vertex Pharmaceuticals Inc
XHAM:VX1
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
V
|
Vertex Pharmaceuticals Inc
XHAM:VX1
|
US |
|
NVIDIA Corp
SIX:NVDA
|
US |
|
China Construction Bank Corp
OTC:CICHF
|
CN |
|
M
|
Microsoft Corp
F:MSF
|
US |
|
B
|
Baloise Holding AG
F:BLO
|
CH |
|
S
|
Syzygy AG
F:SYZ
|
DE |
|
S
|
Stroeer SE & Co KgaA
DUS:SAX
|
DE |
|
Illinois Tool Works Inc
NYSE:ITW
|
US |
|
C
|
Costco Wholesale Corp
BMV:COST
|
US |
|
C
|
Carrefour SA
XBER:CAR
|
FR |
|
M
|
Mastercard Inc
DUS:M4I
|
US |
|
A
|
Alphabet Inc
XBER:ABEA
|
US |
|
F
|
Fiserv Inc
XMUN:FIV
|
US |
|
S
|
Stora Enso Oyj
XMUN:ENUA
|
FI |
|
S
|
Schneider Electric SE
F:SND
|
FR |
|
P
|
Pfizer Inc
SWB:PFE
|
US |
|
D
|
Deutsche Telekom AG
F:DTE
|
DE |
Wall St Price Targets
VX1 Price Targets Summary
Vertex Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for VX1 is 475.91 EUR with a low forecast of 282.82 EUR and a high forecast of 571.11 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is VX1's stock price target?
Price Target
475.91
EUR
According to Wall Street analysts, the average 1-year price target for VX1 is 475.91 EUR with a low forecast of 282.82 EUR and a high forecast of 571.11 EUR.
What is the Revenue forecast for Vertex Pharmaceuticals Inc?
Projected CAGR
10%
Over the last 13 years, the compound annual growth rate for Revenue has been 17%. The projected CAGR for the next 3 years is 10%.
What is the Gross Profit forecast for Vertex Pharmaceuticals Inc?
Projected CAGR
11%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 17%. The projected CAGR for the next 3 years is 11%.
What is the Operating Income forecast for Vertex Pharmaceuticals Inc?
Projected CAGR
17%
Over the last 13 years, the compound annual growth rate for Operating Income has been 42%. The projected CAGR for the next 3 years is 17%.
What is the Pre-Tax Income forecast for Vertex Pharmaceuticals Inc?
Projected CAGR
20%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 47%. The projected CAGR for the next 3 years is 20%.
What is the Net Income forecast for Vertex Pharmaceuticals Inc?
Projected CAGR
18%
The compound annual growth rate for Net Income over the next 3 years is 18%.
